Response to Antiretroviral Therapy in a Patient with an Uncommon Codon 69 Insertion in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase

This publication has 9 references indexed in Scilit:

• The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy.
  1999
• Evidence of Stavudine-Related Phenotypic Resistance Among Zidovudine-Pretreated HIV-1–Infected Subjects Receiving a Therapeutic Regimen of Stavudine Plus Lamivudine
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
• A Family of Insertion Mutations between Codons 67 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Multinucleoside Analog Resistance
  Antimicrobial Agents and Chemotherapy, 1999
• A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.
  Journal of Clinical Investigation, 1998
• Antiretroviral Drug Resistance Testing in Adults With HIV Infection
  JAMA, 1998
• Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial.
  1997
• Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In Vitro
  The Journal of Infectious Diseases, 1996
• Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy
  Journal of Virology, 1996